Pete Gundermann
Analyst · Dougherty. Please proceed with your question
Thank you, Debbie, and good morning, everybody. My agenda is to talk through first our fourth quarter results. We felt the fourth quarter was a little bit later than expected, but a reasonable close to the year and then spend a little of time talking about 2015 in summary which we thought was a great year, solid growth, very good margins, good cash generation and a good balance sheet at the end of the year. And then close the call with some updated revenue guidance for our 2016 year which we are now well into and then turning it over for Q&A. So, as I said, the fourth quarter was a little bit later than we expected. We had some orders fall out of the fourth quarter into the first quarter primarily on the aerospace side. That’s somewhere in the range of $4 million to $5 million in revenue which we don't feel is all that significant from an annual basis, but certainly can move a quarter when you look at that level of detail. I’d like to emphasize, I guess, upfront that we don’t view that slip as some fundamental shift in our market or outlook or prospects in the market. We think things continue to be very strong for our company in general. But revenue in the fourth quarter ended being $157 million, down 5.3% year-over-year mostly because of customer schedules in our test business schedule which we were aware of about a year-ago and was no real surprise, so on the quarter aerospace revenues were up 6.1% year-over-year, test was down substantially, 44%. So with that mix change happening we ended up at $157 million in revenue. Net income was just shy of $14 million or 8.8% of sales, down from $18 million in the fourth quarter last year. Diluted earnings per share of $0.53, down from $0.71 a year ago. Some discussion on the margin profile of the business in the quarter. Our engineering and development expense was $24 million or 15% of sales, that’s higher than we've done in a while primarily because of the lower sales level. That $24 million in E&D expense compares to $20 million a year ago. The other kind of general theme that both for the quarter and for year is that when people compare on the aerospace side, specifically our margin profile this year compared to our margin profile last year, one of the changes that we have been wrestling with is our Armstrong acquisition from earlier in the year. That revenue and the contribution there definitely was a little bit of a drug on margin. So to the extent that people want to look at the year-over-year changes and try to make of sense of it between the E&D expense across the company and the kind of addition of Armstrong that more than explains those margin differences especially on the aerospace side. We also had very low taxes in the fourth quarter, 6.2%, due to passing of the R&D tax credit and I guess to complete the round, bookings were $135 million, that’s a little on the late side for us and certainly worthy of discussion is the fact that we have not received yet a substantial order that we anticipated in December for our test business on semiconductor side to boost the prospects for 2016 and we will talk about that. We expect an order, there is one coming. It’s perhaps not going to be as big as we originally expected, but I will talk about that in some detail when we get to the test business summary here. Our ending backlog at the end of the year was $247 million, we think putting us in pretty shape going into 2016. When you look at 2015 as a year of the final numbers, revenue of $692 million, up 4.7%. Aerospace was up 11% at $550 million, that’s $55 million increase. 6% of the 11.1% growth was organic. The remainder 5.1% came from the Armstrong acquisition, so half the growth was organic, half of it was from Armstrong. Our test business ended up with revenues of $142 million, that’s down $23 million or 14% from 2014. With that mix change, we still managed to be pretty profitable. Consolidated net income was $67 million, up almost 20% from $56 million net income in 2014. On a margin basis, that’s 9.7% of sales net income versus 8.5% in 2014 and $2.55 per diluted share versus $2.16 against the margin discussion. In 2014 we had a substantial amount of inventory write-up expense, $19.4 million for the year versus only $1 million in 2015. That change definitely helped 2015 results. Moving the other way, our engineering and development expense in 2015 ended up being $90 million to 13% of sales, up from $77 million or 11.6% of sales in 2014. And again, we experienced some margin pressure at Armstrong which when you look at the aerospace margins year to year, was definitely a factor. Our 2015 bookings for the year were $585 million. That’s the book-to-bill ratio of 0.84, but looking again at the segments, our book-to-bill in aerospace was $0.96, so the bookings definitely have kept up with the shipments or very close it, but our book-to-bill on the test side was 0.4, which reflects again the order that we didn't get in December as we expected. So that ratio will we believe flip around pretty quickly here in the coming weeks. Looking at the segments more specifically, aerospace first made up 87% of our fourth quarter shipments, 80% for the year. Revenues in the fourth quarter, as I said, were $136 million, up $7.9 million or 6.1% from 2014. Probably worth mentioning, especially for the aerospace business that our comparative quarter was a record quarter. In fact, we are lined up here. We are lined up here for a series of pretty difficult comparisons on the aerospace side because we have had some very good results from late 2014 through 2015. Operating profit in the quarter was $18.4 million or 13.5%. The comparative quarter last year was $19.4 million or 15.1%. Revenues for the entire year were $550 million, up 11% over 2014. Armstrong contributed $25.5 million, so organic growth was about $29.5 million or 6%. When you look at our product lines, our Electrical Power & Motion product line is our biggest product line responsible for 51% of our aerospace revenues in 2015, that’s about $280 million. The product grouping was up 9.9% or $25 million from 2014. A lot of people like to talk about our in-seat power product franchise. That one led the way. It’s buried in that Electrical Power & Motion sales grouping, but our in-seat power product was up just shy of 15% for the year in 2015. Our lighting and safety sales were $157 million for the year, up $9 million or 6% in our avionics product grouping or one of our smaller ones $56 million in revenue for the year, down 3% year-over-year. Our system certification sales were $21 million, that all comes from the Armstrong acquisition. Armstrong obviously has other sales which were grouped into our other product lines. Our operating profit for the aerospace segment year-to-date was $85 million or 15.5%. $85 million is up from $79 million a year before, but 15.5% is down from 16.1%. That margin, again, we would suggest is - can easily be attributed to increased E&D expense and the addition of Armstrong to the business. Our bookings in the fourth quarter for aerospace were $122 million, somewhat behind recent quarters, but in general on the pace and bookings for the year were $527 million with book-to-bill of, as I said earlier, 0.96. We had for the year two reportable major aerospace customers. We will identify them in our K which will be filed in the coming weeks. One was $145 million or 21% of consolidated sales, the other at $90 million in revenues, 13% of consolidated sales. Moving to our test systems segment, it was a weak fourth quarter as we expected primarily just due to the scheduling of customer deliveries primarily on the semiconductor side. $20.8 million in revenue in the fourth quarter down from $37.7 million in the previous year. For 2015 revenues were $142.6 million down from $166.8 million, but operating profit was $25.5 million or 17.9% substantially up from $12.4 million in 2014 which was 7.4% of revenues in that year. In 2014, to put the margins in perspective, there was inventory step-up expense of about $16.8 million on the test side of our business. Bookings were $13 million in the fourth quarter, $57 million for the year. We issued initial revenue guidance for 2016 in November and at the time, we had a negotiated agreement with the substantial customer for an order that expected to receive in December and for reasons that aren’t very clearly known to us, but I think if you read the press and you understand that we do business with a lot of name brands, very large companies. That demand that was anticipated by the customer in September, October declined and we have spent the time since then renegotiating a smaller demand for 2016, which we believe is done at this point, the negotiations, but the order has not yet been received. So we are kind of in the same spot now in terms of having what we believe is the pretty clear line of sight so what demand is going to be and yet we don’t have the order. So the schedule is such that we would expect an order to be coming in the next, say, four to eight weeks. It could be any day. We don’t have insight into those internal processes that we will of course based on the size of it confirm receipt in the press release as soon as possible. So, our fourth quarter backlog for the test side at the end of the year was $61.7 million. We clearly need the new order to make the forecast that we are putting out today. Looking back at 2015 by the SEC’s requirements we have had one significant customer that came in at about $90 million in sales, 13% of consolidated. The balance sheet at the end we feel we made substantial progress. We had cash on hand at $18.6 million, outstanding debt of $170 million, so a net debt of $151 million. We think that puts us in a pretty conservative camp and [indiscernible] take advantage of opportunities as they may present themselves. So looking forward, last November we issued initial 2016 revenue guidance of $690 million to $750 million based pretty much solely on the evolution with our large semiconductor customer. We are revising that now to $665 million to $725 million. Our aerospace segment forecasts remains as it was, $572 million to $617 million. Our test business revenue forecast is revised to be in the range of $93 million to $109 million. That implies growth rates in aerospace somewhere between 4% and 13%. That implies our test business will be down somewhere in the neighborhood of 30% in revenue year-over-year. CapEx planned to be in the $25 million to $30 million range in 2016, and our engineering and development expense, we believe will be about the same level as 2015, about $90 million, which works to be about 13% of revenues at the midpoint. So one other comment I guess on the Test business in general, and it’s a matter of perspective I suppose many of these things are, we own in that business, the Irvine operation specifically for a couple of years, and it’s been an interesting ride and we are expecting - we saw revenue decline in 2015, we saw - we are expecting a revenue decline in 2016 and yet, I can tell you, from my perspective, we have seen tremendous in the margin profile, and we have seen tremendous development of the organization in terms of competency and product offering and very good execution on the ground. And in the short-term, we are somewhat locked in to the programs we liked into, we expect as I said, revenue to be down about 30% this year. On the other hand, it is very clear that the skillsets that we bring to the market, the products that we have to offer and are in strong demand. And the customers are enthusiastic about the capabilities that we can offer. And our thinking, my thinking beyond 2016 is that it’s a bright future. We have got we believe a favorable trend developing in our aerospace and defense side of our Test business. I think the ground that we have covered in the semiconductor side has been not much short of spectacular in terms of appreciation from our customers and recognition in the market. And I think we feel that over time, we are going to have an increase opportunities that both in the aerospace and defense side as well as the semiconductor side and we need to get through this coming year. I look back at what we paid for that business, I look at what the returns have been, I think it’s been a worthwhile contribution and we’re excited to see how it continues to work out. So I think those are my prepared comments and Kevin, if you’re still there, why don’t we open it up for questions?